Media stories about Transcat (NASDAQ:TRNS) have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group identifies positive and negative news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Transcat earned a media sentiment score of 0.22 on Accern’s scale. Accern also assigned news articles about the scientific and technical instruments company an impact score of 48.1606860062377 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

TRNS stock traded up $0.45 during midday trading on Friday, hitting $24.20. 737 shares of the stock traded hands, compared to its average volume of 20,175. The firm has a market cap of $170.28 million, a PE ratio of 34.08, a P/E/G ratio of 3.05 and a beta of 0.38. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.33 and a current ratio of 2.04. Transcat has a 1-year low of $12.00 and a 1-year high of $23.90.

Transcat (NASDAQ:TRNS) last released its quarterly earnings results on Wednesday, July 25th. The scientific and technical instruments company reported $0.19 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.17 by $0.02. The company had revenue of $36.66 million for the quarter, compared to analyst estimates of $38.30 million. Transcat had a net margin of 4.18% and a return on equity of 11.55%. research analysts predict that Transcat will post 0.97 earnings per share for the current fiscal year.

Separately, Zacks Investment Research upgraded shares of Transcat from a “hold” rating to a “buy” rating and set a $22.00 price target on the stock in a research report on Friday, June 15th. Five investment analysts have rated the stock with a buy rating, Transcat presently has an average rating of “Buy” and an average price target of $21.25.

In other Transcat news, Chairman Charles P. Hadeed sold 17,700 shares of the stock in a transaction on Wednesday, May 30th. The shares were sold at an average price of $18.18, for a total transaction of $321,786.00. Following the transaction, the chairman now directly owns 77,474 shares of the company’s stock, valued at $1,408,477.32. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Alan H. Resnick sold 1,916 shares of the stock in a transaction on Friday, June 8th. The shares were sold at an average price of $19.79, for a total transaction of $37,917.64. Following the transaction, the director now directly owns 35,400 shares in the company, valued at $700,566. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 30,255 shares of company stock worth $469,011. Insiders own 8.80% of the company’s stock.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in North America and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Read More: How Short Selling Works

Insider Buying and Selling by Quarter for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with's FREE daily email newsletter.